This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brinkman-Van der Linden, E. C. M.
Right arrow Articles by Varki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brinkman-Van der Linden, E. C. M.
Right arrow Articles by Varki, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2003, p. 4199-4206, Vol. 23, No. 12
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.12.4199-4206.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

CD33/Siglec-3 Binding Specificity, Expression Pattern, and Consequences of Gene Deletion in Mice

Els C. M. Brinkman-Van der Linden,1,{dagger} Takashi Angata,1 Shirley A. Reynolds,1,2,>{ddagger} Leland D. Powell,1,§ Stephen M. Hedrick,1,2 and Ajit Varki1*

Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine,1 Molecular Biology Section, Division of Biology, University of California, San Diego, La Jolla, California 92093-06872

Received 9 December 2002/ Returned for modification 4 February 2003/ Accepted 26 March 2003

Mouse CD33/Siglec-3 (mCD33) is the apparent ortholog of human CD33/Siglec-3 (hCD33), a member of the Siglec (sialic acid-binding Ig superfamily lectin) family of sialic acid-recognizing cell-surface lectins. We examined the binding specificity and expression pattern of mCD33 and explored its functions by generating mice deficient in this molecule. Like hCD33, mCD33 is expressed on myeloid precursors in the bone marrow, albeit mostly in the more mature stages of the granulocytic lineage. Moreover, unlike hCD33, mCD33 in peripheral blood is primarily expressed on granulocytes. Also, unlike hCD33, mCD33 did not bind to {alpha}2-3- or {alpha}2-6-linked sialic acids on lactosamine units. Instead, it showed distinctive sialic acid-dependent binding only to the short O-linked glycans of certain mucins and weak binding to the sialyl-Tn epitope. Binding was enhanced by removal of 9-O-acetyl groups and attenuated by truncation of the glycerol-like side chain of sialic acids. Mice deficient in CD33 were viable and fertile in a controlled-access specific-pathogen-free vivarium, showed no major morphological or histological abnormalities, had no changes in bone marrow or peripheral leukocyte subpopulations, and had very minor differences in biochemical and erythrocyte parameters. Cellular responses to intraperitoneally injected proinflammatory stimulants, as well as subsequent interleukin-6 secretion, were also apparently unaffected. These results indicate substantial species differences in CD33 expression patterns and ligand recognition and suggest functional degeneracy between mCD33 and the other CD33-related Siglec proteins expressed on cells of the myeloid lineage.


* Corresponding author. Mailing address: University of California, San Diego, School of Medicine, La Jolla, CA 92093-0687. Phone: (858) 534-3296. Fax: (858) 534-5611. E-mail: avarki{at}ucsd.edu.

{dagger} Present address: Neose Technologies, Inc., San Diego, CA 92121.

{ddagger} Present address: UCSD Medical Center, San Diego, CA 92103.

§ Present address: Department of Medicine, Olive View-UCLA Medical Center, Sylmar, CA 91342.


Molecular and Cellular Biology, June 2003, p. 4199-4206, Vol. 23, No. 12
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.12.4199-4206.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Zhang, M., Angata, T., Cho, J. Y., Miller, M., Broide, D. H., Varki, A. (2007). Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109: 4280-4287 [Abstract] [Full Text]  
  • Angata, T., Hayakawa, T., Yamanaka, M., Varki, A., Nakamura, M. (2006). Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 20: 1964-1973 [Abstract] [Full Text]  
  • Zhang, J., Raper, A., Sugita, N., Hingorani, R., Salio, M., Palmowski, M. J., Cerundolo, V., Crocker, P. R. (2006). Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107: 3600-3608 [Abstract] [Full Text]  
  • Varki, A., Angata, T. (2006). Siglecs--the major subfamily of I-type lectins. Glycobiology 16: 1R-27R [Abstract] [Full Text]  
  • Bochner, B. S., Alvarez, R. A., Mehta, P., Bovin, N. V., Blixt, O., White, J. R., Schnaar, R. L. (2005). Glycan Array Screening Reveals a Candidate Ligand for Siglec-8. J. Biol. Chem. 280: 4307-4312 [Abstract] [Full Text]  
  • Mestas, J., Hughes, C. C. W. (2004). Of Mice and Not Men: Differences between Mouse and Human Immunology. J. Immunol. 172: 2731-2738 [Abstract] [Full Text]